BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SCC-25 cell line is 22
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 32327629 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting and FACs followed by SFA | NA | 0.52 | 1 | 34795388 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | FACs | NA | 0.52 | 1 | 29515788 |
| HIF1A | 4910 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | qPCR followed by Western Blotting and SFA | NA | 0.48 | 0.0106 | 35013621 |
| NOTCH1 | 7881 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | qPCR followed by Western Blotting and SFA | NA | 0.48 | 0.0477 | 35013621 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.684 | 34795388 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | ALDEFLUOR assay | NA | 0.28 | 0.684 | 29515788 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34795388 |
| CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.456 | 32327629 |
| MSI1 | 7330 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 32327629 |
| MYC | 7553 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1304 | 35013621 |
| MYC | 7553 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 32327629 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.5461 | 34795388 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5461 | 35013621 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 32327629 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.6448 | 34795388 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.6448 | 35013621 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 32327629 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.5695 | 34795388 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5695 | 35013621 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 32327629 |
| PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-25 | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.7582 | 34795388 |